PMN
PMN
NASDAQ · Biotechnology

Promis Neurosciences Inc

$12.73
-0.37 (-2.82%)
As of Feb 8, 2:23 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.59M 3.48M 3.01M
Net Income 732.2K 573.7K 520.4K
EPS
Profit Margin 20.4% 16.5% 17.3%
Rev Growth +3.4% -1.6% +9.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 5.02M 4.83M 4.48M
Total Equity 17.93M 18.85M 18.29M
D/E Ratio 0.28 0.26 0.25
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.09M 1.00M 849.7K
Free Cash Flow 537.7K 589.4K 453.2K